Author guidelines

Requirements for manuscripts submitted to Pharmacognosy Communications (ISSN 2249-0167). Submissions that do not meet these requirements are returned to the corresponding author before peer review.

Manuscript preparation

Submit the manuscript as a single editable file with continuous line numbering and double spacing throughout.

Title page: full title, running head, author names, affiliations, ORCID iDs and the corresponding author's email.
Structured abstract of up to 250 words followed by 4–6 keywords.
Main text ordered as Introduction, Materials and Methods, Results, Discussion, Conclusion.
Figures at 300 dpi minimum; tables as editable text, never as images.

References and citations

References follow APA 7 with hanging indents and alphabetical ordering; in-text citations must resolve to a listed reference.

Include DOIs for every reference where one exists.
Cite primary sources; limit unpublished or personal communications.
Self-citation should not exceed 15% of the reference list.

Ethics and declarations

Every submission carries the declarations required by the journal's editorial policy.

Ethical approval and informed-consent statements for studies involving humans or animals.
Conflict-of-interest and funding disclosures for all authors.
Data availability statement naming the repository or reason for restriction.
Similarity screening: manuscripts above the accepted threshold are returned before review.

Peer review and decisions

Manuscripts are screened editorially and then sent to at least two independent referees under single-blind review.

First decision is normally returned within four weeks of assignment.
Revisions must be accompanied by a point-by-point response to each referee.
Accepted articles appear in press ahead of issue assignment.

The full, authoritative guidelines for Pharmacogn. Commn. are maintained on the journal's own site. Open the journal guidelines ↗

Submit a manuscript ↗